EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein

Qian Yang, Mengru Yan, Juan Lin, Yongkang Lu, Shuang Lin, Zhong Li, He Wang, Juhua Yang, Nanwen Zhang, Xiaole Chen

PeerJ · 2024

DOI: 10.7717/peerj.17846 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Qian Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering and Biopharmaceutics, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Single-Domain Antibodies, SARS-CoV-2, Coronavirus Nucleocapsid Proteins, COVID-19. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation, China, Natural Science Foundation of Fujian Province, China, Fujian Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronavirus disease 2019 (COVID-19) pandemic, which caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), lead to a crisis with devastating disasters to global public economy and health. Several studies suggest that the SARS-CoV-2 nucleocapsid protein (N protein) is one of uppermost structural constituents of SARS-CoV-2 and is relatively conserved which could become a specific diagnostic marker. In this study, eight single domain antibodies recognized the N protein specifically which were named pN01–pN08 were screened using human phage display library. According to multiple sequence alignment and molecular docking analyses, the interaction mechanism between antibody and N protein was predicted. ELISA results indicated pN01–pN08 with high affinity to protein N. To improve their efficacy, two fusion proteins were prepared and their affinity was tested. These finding showed that fusion proteins had higher affinity than single domain antibodies and will be used as diagnosis for the pandemic of SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesSARS-CoV-2Coronavirus Nucleocapsid ProteinsCOVID-19Molecular Docking SimulationAntibodies, ViralHumansAntibody AffinityPhosphoproteinsEnzyme-Linked Immunosorbent AssayRecombinant Fusion ProteinsPeptide Library

Stichwörter der Autor:innen

Fusion proteinPhage displaySARS-CoV-2Single domain antibody

Substanzen

Single-Domain AntibodiesCoronavirus Nucleocapsid ProteinsAntibodies, Viralnucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsRecombinant Fusion ProteinsPeptide Library

Autor:innen und Institutionen

  • Department of Bioengineering and Biopharmaceutics, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
  • Fujian Key Laboratory of Natural Medicine Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, China.
  • Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
  • Department of Pharmacology, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
  • Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, Fuzhou, Fujian, China.

Förderung

  • National Natural Science Foundation, China
  • Natural Science Foundation of Fujian Province, China
  • Fujian Medical University

Zitieren

APA

Yang, Q., Yan, M., Lin, J., Lu, Y., Lin, S., Li, Z., Wang, H., Yang, J., Zhang, N., & Chen, X. (2024). Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein. PeerJ. https://doi.org/10.7717/peerj.17846

Vancouver

Yang Q, Yan M, Lin J, Lu Y, Lin S, Li Z, et al. Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein. PeerJ. 2024. doi:10.7717/peerj.17846

BibTeX
@article{Yang2024,
  author = {Yang, Qian and Yan, Mengru and Lin, Juan and Lu, Yongkang and Lin, Shuang and Li, Zhong and Wang, He and Yang, Juhua and Zhang, Nanwen and Chen, Xiaole},
  title = {Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein},
  journal = {PeerJ},
  year = {2024},
  doi = {10.7717/peerj.17846}
}
Kostenlos starten →